首先看消息:
On August 30, 2018, Citron Research published a report stating that “Cronos management appears to have been deceiving the investing public by purposely not disclosing the size of its distribution agreements with provinces – unlike every other major cannabis player . . . because the agreements are so small they could never justify the premium investors are paying for the stock.” On this news, shares of Cronos have fallen sharply during intraday trading on August 30, 2018.
这并不是太坏的消息,但股价跌30%。先在$8。93买一部分。